{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T01:35:06Z","timestamp":1777858506815,"version":"3.51.4"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T00:00:00Z","timestamp":1774137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-04874-9","type":"journal-article","created":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T12:53:50Z","timestamp":1774184030000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Probing uric acid-related prognostic genes and their molecular mechanisms in prostate cancer based on transcriptomic data"],"prefix":"10.1007","volume":"17","author":[{"given":"Xin","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaodong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongwei","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haibin","family":"Ling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangdong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,22]]},"reference":[{"key":"4874_CR1","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/s41585-025-01014-w","volume":"22","author":"B Cristina","year":"2025","unstructured":"Cristina B, Tarek TV, Balaji V, et al. Targeting the tumour cell surface in advanced prostate cancer. Nat Rev Urol. 2025;22:569\u201389.","journal-title":"Nat Rev Urol"},{"key":"4874_CR2","first-page":"485","volume":"75","author":"B Tyler","year":"2025","unstructured":"Tyler B, Kratzer,Natalia M, Jessica S, et al. Prostate cancer statistics, 2025. CA Cancer J Clin. 2025;75:485\u201397.","journal-title":"CA Cancer J Clin"},{"key":"4874_CR3","unstructured":"Roberts MJ, Teloken P, Chambers SK et al. Prostate cancer detection. In: Feingold KR, Ahmed SF, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, de Herder WW, Dhatariya K (Eds.) Endotext. Dungan K South Dartmouth (MA); 2000."},{"key":"4874_CR4","doi-asserted-by":"crossref","unstructured":"Kulac I, Roudier MP, Haffner MC. Molecular Pathology of Prostate Cancer. Surg Pathol Clin. 2021;14:387\u2013401.","DOI":"10.1016\/j.path.2021.05.004"},{"key":"4874_CR5","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.eururo.2023.04.021","volume":"84","author":"O Bergengren","year":"2023","unstructured":"Bergengren O, Pekala KR, Matsoukas K, et al. 2022 Update on Prostate Cancer Epidemiology and Risk Factors-A Systematic Review. Eur Urol. 2023;84:191\u2013206. https:\/\/doi.org\/10.1016\/j.eururo.2023.04.021.","journal-title":"Eur Urol"},{"key":"4874_CR6","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa1011967","volume":"364","author":"A Bill-Axelson","year":"2011","unstructured":"Bill-Axelson A, Holmberg L, Ruutu M, et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med. 2011;364:1708\u201317. https:\/\/doi.org\/10.1056\/NEJMoa1011967.","journal-title":"N Engl J Med"},{"key":"4874_CR7","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1053\/j.semnuclmed.2015.10.005","volume":"46","author":"S Evans-Axelsson","year":"2016","unstructured":"Evans-Axelsson S, Timmermand OV, Bjartell A, et al. Radioimmunotherapy for prostate cancer\u2014current status and future possibilities. Semin Nucl Med. 2016;46:165\u201379. https:\/\/doi.org\/10.1053\/j.semnuclmed.2015.10.005","journal-title":"Semin Nucl Med"},{"key":"4874_CR8","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1007\/s00394-022-03076-7","volume":"62","author":"Y Deng","year":"2023","unstructured":"Deng Y, Huang J, Wong MCS. Association between serum uric acid and prostate cancer risk in East Asian populations: a Mendelian randomization study. Eur J Nutr. 2023;62:1323\u20139. https:\/\/doi.org\/10.1007\/s00394-022-03076-7.","journal-title":"Eur J Nutr"},{"key":"4874_CR9","doi-asserted-by":"publisher","first-page":"96","DOI":"10.36922\/JCTR025260029","volume":"11","author":"CTA Randi","year":"2025","unstructured":"Randi CTA, Donlon,Richard C, Allsopp, et al. Association between serum uric acid and prostate cancer risk: the modifying role of CTGF genotype. J Clin Transl Res. 2025;11:96\u2013105.","journal-title":"J Clin Transl Res"},{"key":"4874_CR10","first-page":"e18761429350210","volume":"17","author":"A Socorro","year":"2025","unstructured":"Socorro A, Anne C-A, Aldo S. Chrysin: a potential antiandrogen ligand to mutated androgen receptors in prostate cancer. Curr Mol Pharmacol. 2025;17:e18761429350210.","journal-title":"Curr Mol Pharmacol"},{"key":"4874_CR11","doi-asserted-by":"publisher","first-page":"608311","DOI":"10.3389\/fgene.2021.608311","volume":"12","author":"J Minxiao","year":"2021","unstructured":"Minxiao J, Liangliang R, Songzan C, et al. Serum uric acid levels and risk of eight site-specific cancers: a mendelian randomization study. Front Genet. 2021;12:608311.","journal-title":"Front Genet"},{"key":"4874_CR12","doi-asserted-by":"publisher","unstructured":"Ganz M, Alessandro C, Jacobs M, et al. Investigating the anti-inflammatory effect of allopurinol on the prevention of prostate cancer. Cureus. 2023;15:e40058. https:\/\/doi.org\/10.7759\/cureus.40058.","DOI":"10.7759\/cureus.40058"},{"key":"4874_CR13","first-page":"61","volume":"31","author":"L Zhong","year":"2023","unstructured":"Zhong L, Yunfeng S, Haoran W, et al. Novel circular RNA CircUBAP2 drives tumor progression by regulating the miR-143\/TFAP2B axis in prostate cancer. Protein Pept Lett. 2023;31:61\u201373.","journal-title":"Protein Pept Lett"},{"key":"4874_CR14","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41391-022-00597-4","volume":"27","author":"V Kukko","year":"2024","unstructured":"Kukko V, Kaipia A, Talala K, et al. Allopurinol and prostate cancer survival in a Finnish population-based cohort. Prostate Cancer Prostatic Dis. 2024;27:73\u201380. https:\/\/doi.org\/10.1038\/s41391-022-00597-4.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"4874_CR15","first-page":"e14200","volume":"53","author":"S Soheila","year":"2021","unstructured":"Soheila S, Sadra R, Farshad N, et al. Is there relationship between serum uric acid levels and lower urinary tract symptoms, prostate volume, and PSA in men without cancer? A prospective population-based study. Andrologia. 2021;53:e14200.","journal-title":"Andrologia"},{"key":"4874_CR16","doi-asserted-by":"publisher","first-page":"103847","DOI":"10.1016\/j.numecd.2025.103847","volume":"35","author":"A Ameneh","year":"2025","unstructured":"Ameneh A, Farzad E, Mitra H, et al. The association between serum uric acid and metabolic syndrome and its components: a decade follow-up in the Tehran lipid and glucose study. Nutr Metab Cardiovasc Dis. 2025;35:103847.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"4874_CR17","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/s41043-025-00982-4","volume":"44","author":"M Mohammad","year":"2025","unstructured":"Mohammad M, Shahad A, Lama A, et al. Impact of lifestyle factors and dietary patterns on serum uric acid levels and disease activity in gout: a systematic review. J Health Popul Nutr. 2025;44:223.","journal-title":"J Health Popul Nutr"},{"key":"4874_CR18","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550. https:\/\/doi.org\/10.1186\/s13059-014-0550-8.","journal-title":"Genome Biol"},{"key":"4874_CR19","doi-asserted-by":"publisher","first-page":"3844","DOI":"10.1093\/bioinformatics\/btac409","volume":"38","author":"EK Gustavsson","year":"2022","unstructured":"Gustavsson EK, Zhang D, Reynolds RH, Garcia-Ruiz S, Ryten M. ggtranscript: an R package for the visualization and interpretation of transcript isoforms using ggplot2. Bioinformatics. 2022;38:3844\u20136. https:\/\/doi.org\/10.1093\/bioinformatics\/btac409.","journal-title":"Bioinformatics"},{"key":"4874_CR20","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1093\/bioinformatics\/btab806","volume":"38","author":"Z Gu","year":"2022","unstructured":"Gu Z, Hubschmann D. Make interactive complex heatmaps in R. Bioinformatics. 2022;38:1460\u20132. https:\/\/doi.org\/10.1093\/bioinformatics\/btab806.","journal-title":"Bioinformatics"},{"key":"4874_CR21","doi-asserted-by":"publisher","first-page":"906753","DOI":"10.3389\/fcvm.2022.906753","volume":"9","author":"Z Yue","year":"2022","unstructured":"Yue Z, Wenqing G, Qiang Z, et al. Ferroptosis and autophagy-related genes in the pathogenesis of ischemic cardiomyopathy. Front Cardiovasc Med. 2022;9:906753.","journal-title":"Front Cardiovasc Med"},{"key":"4874_CR22","doi-asserted-by":"publisher","first-page":"906753","DOI":"10.3389\/fcvm.2022.906753","volume":"9","author":"Y Zheng","year":"2022","unstructured":"Zheng Y, Gao W, Zhang Q, et al. Ferroptosis and Autophagy-Related Genes in the Pathogenesis of Ischemic Cardiomyopathy. Front Cardiovasc Med. 2022;9:906753. https:\/\/doi.org\/10.3389\/fcvm.2022.906753.","journal-title":"Front Cardiovasc Med"},{"key":"4874_CR23","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. Omics. 2012;16:284\u20137. https:\/\/doi.org\/10.1089\/omi.2011.0118.","journal-title":"Omics"},{"key":"4874_CR24","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498\u2013504. https:\/\/doi.org\/10.1101\/gr.1239303.","journal-title":"Genome Res"},{"key":"4874_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.scog.2017.10.001","volume":"11","author":"IS Ramsay","year":"2018","unstructured":"Ramsay IS, Ma S, Fisher M, et al. Model selection and prediction of outcomes in recent onset schizophrenia patients who undergo cognitive training. Schizophr Res Cogn. 2018;11:1\u20135. https:\/\/doi.org\/10.1016\/j.scog.2017.10.001.","journal-title":"Schizophr Res Cogn"},{"key":"4874_CR26","doi-asserted-by":"publisher","first-page":"11340","DOI":"10.1038\/s41598-022-15609-5","volume":"12","author":"Y Li","year":"2022","unstructured":"Li Y, Lu F, Yin Y. Applying logistic LASSO regression for the diagnosis of atypical Crohn\u2019s disease. Sci Rep. 2022;12:11340. https:\/\/doi.org\/10.1038\/s41598-022-15609-5.","journal-title":"Sci Rep"},{"key":"4874_CR27","doi-asserted-by":"publisher","DOI":"10.18637\/jss.v106.i01","author":"JK Tay","year":"2023","unstructured":"Tay JK, Narasimhan B, Hastie T. Elastic Net Regularization Paths for All Generalized Linear Models. J Stat Softw. 2023. https:\/\/doi.org\/10.18637\/jss.v106.i01.","journal-title":"J Stat Softw"},{"key":"4874_CR28","doi-asserted-by":"publisher","first-page":"2509757","DOI":"10.1080\/21505594.2025.2509757","volume":"16","author":"C Xinyi","year":"2025","unstructured":"Xinyi C, Wenyi C, Jiahang Z, et al. Association between early antibiotic treatment after admission and mortality of acute-on-chronic liver failure patients with bacterial infection: a multicenter retrospective study. Virulence. 2025;16:2509757.","journal-title":"Virulence"},{"key":"4874_CR29","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/j.0006-341x.2000.00337.x","volume":"56","author":"PJ Heagerty","year":"2000","unstructured":"Heagerty PJ, Lumley T, Pepe MS. Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics. 2000;56:337\u201344. https:\/\/doi.org\/10.1111\/j.0006-341x.2000.00337.x.","journal-title":"Biometrics"},{"key":"4874_CR30","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/978-1-4939-7493-1_12","volume":"1711","author":"B Chen","year":"2018","unstructured":"Chen B, Khodadoust MS, Liu CL, Newman AM, Alizadeh AA. Profiling tumor infiltrating immune cells with CIBERSORT. Methods Mol Biol. 2018;1711:243\u201359. https:\/\/doi.org\/10.1007\/978-1-4939-7493-1_12.","journal-title":"Methods Mol Biol"},{"key":"4874_CR31","doi-asserted-by":"publisher","first-page":"591937","DOI":"10.3389\/fonc.2020.591937","volume":"10","author":"J Zheng","year":"2020","unstructured":"Zheng J, Zhang T, Guo W, et al. Integrative Analysis of Multi-Omics Identified the Prognostic Biomarkers in Acute Myelogenous Leukemia. Front Oncol. 2020;10:591937. https:\/\/doi.org\/10.3389\/fonc.2020.591937.","journal-title":"Front Oncol"},{"key":"4874_CR32","doi-asserted-by":"crossref","unstructured":"Chun-Jie F-FH, Lan-Lan L. Liu Expression profile of immune checkpoint genes and their roles in predicting immunotherapy response. Brief Bioinform. 2020. 22:bbaa176","DOI":"10.1093\/bib\/bbaa176"},{"key":"4874_CR33","doi-asserted-by":"crossref","unstructured":"Geeleher P, Cox N, Huang RS. pRRophetic: an R package for prediction of clinical chemotherapeutic response from tumor gene expression levels. PLoS ONE. 2014;9:e107468.","DOI":"10.1371\/journal.pone.0107468"},{"key":"4874_CR34","doi-asserted-by":"crossref","unstructured":"Qin Y, Xin L. Pan-cancer analysis of ADAR1 with its prognostic relevance in low-grade glioma. Immunobiology. 2024. 229: 152855","DOI":"10.1016\/j.imbio.2024.152855"},{"key":"4874_CR35","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1101\/gr.239244.118","volume":"28","author":"A Mayakonda","year":"2018","unstructured":"Mayakonda A, Lin DC, Assenov Y, Plass C, Koeffler HP. Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res. 2018;28:1747\u201356. https:\/\/doi.org\/10.1101\/gr.239244.118.","journal-title":"Genome Res"},{"issue":"11","key":"4874_CR36","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1101\/gr.239244.118","volume":"28","author":"A Mayakonda","year":"2018","unstructured":"Mayakonda A, Lin DC, Assenov Y, Plass C, Koeffler HP. Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res. 2018;28(11):1747\u201356. https:\/\/doi.org\/10.1101\/gr.239244.118.","journal-title":"Genome Res"},{"key":"4874_CR37","doi-asserted-by":"crossref","unstructured":"Tianzhi W, Erqiang H, Shuangbin X, et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innov (Camb). 2021;2:100141.","DOI":"10.1016\/j.xinn.2021.100141"},{"key":"4874_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232214257","author":"S Wasim","year":"2022","unstructured":"Wasim S, Lee SY, Kim J. Complexities of prostate cancer. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms232214257.","journal-title":"Int J Mol Sci"},{"key":"4874_CR39","doi-asserted-by":"publisher","first-page":"1354235","DOI":"10.3389\/fonc.2024.1354235","volume":"14","author":"Y Yan","year":"2024","unstructured":"Yan Y, Lin H, He Z, Wang L. Serum uric acid and prostate cancer: findings from the NHANES (2007\u20132020). Front Oncol. 2024;14:1354235. https:\/\/doi.org\/10.3389\/fonc.2024.1354235.","journal-title":"Front Oncol"},{"key":"4874_CR40","doi-asserted-by":"publisher","first-page":"e0320738","DOI":"10.1371\/journal.pone.0320738","volume":"20","author":"Y Yao","year":"2025","unstructured":"Yao Y, Liyin Z, Jiaoyue, Zhang, et al. Predictive value of uric acid to albumin ratio for carotid atherosclerosis in type 2 diabetes mellitus: a retrospective study. PLoS ONE. 2025;20:e0320738.","journal-title":"PLoS ONE"},{"key":"4874_CR41","doi-asserted-by":"publisher","first-page":"157386","DOI":"10.1016\/j.phymed.2025.157386","volume":"148","author":"T Chao-Tao","year":"2025","unstructured":"Chao-Tao T, Yonghui W, Yiyi J, et al. Brevilin A suppresses lipid metabolism reprogramming in colorectal adenoma-to-adenocarcinoma sequence via the NR1D1\/APOH signaling axis. Phytomedicine. 2025;148:157386. https:\/\/pubmed.ncbi.nlm.nih.gov\/41110356\/","journal-title":"Phytomedicine"},{"key":"4874_CR42","doi-asserted-by":"publisher","first-page":"352","DOI":"10.5507\/bp.2015.018","volume":"159","author":"AM Dabrowska","year":"2015","unstructured":"Dabrowska AM, Tarach JS, Wojtysiak-Duma B, Duma D. Fetuin-A (AHSG) and its usefulness in clinical practice. Review of the literature. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2015;159:352\u20139. https:\/\/doi.org\/10.5507\/bp.2015.018.","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"key":"4874_CR43","doi-asserted-by":"publisher","first-page":"7659","DOI":"10.1007\/s11033-023-08623-x","volume":"50","author":"X Xing","year":"2023","unstructured":"Xing X, Cao F, Gao L, Song M. AHSG, a gene promoting tumour proliferation, migration and invasion, is an independent prognostic factor for poor overall survival in lung adenocarcinoma. Mol Biol Rep. 2023;50:7659\u201366. https:\/\/doi.org\/10.1007\/s11033-023-08623-x.","journal-title":"Mol Biol Rep"},{"key":"4874_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19082211","author":"J Ochieng","year":"2018","unstructured":"Ochieng J, Nangami G, Sakwe A, et al. Impact of Fetuin-A (AHSG) on tumor progression and type 2 diabetes. Int J Mol Sci. 2018. https:\/\/doi.org\/10.3390\/ijms19082211.","journal-title":"Int J Mol Sci"},{"key":"4874_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252312918","author":"P Odiase","year":"2024","unstructured":"Odiase P, Ma J, Ranganathan S, et al. The role of Fetuin-A in tumor cell growth, prognosis, and dissemination. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms252312918.","journal-title":"Int J Mol Sci"},{"key":"4874_CR46","doi-asserted-by":"publisher","first-page":"14282","DOI":"10.1080\/21655979.2022.2081465","volume":"13","author":"Y Dong","year":"2022","unstructured":"Dong Y, Ding D, Gu J, Chen M, Li S. Alpha-2 Heremans Schmid Glycoprotein (AHSG) promotes the proliferation of bladder cancer cells by regulating the TGF-beta signalling pathway. Bioengineered. 2022;13:14282\u201398. https:\/\/doi.org\/10.1080\/21655979.2022.2081465.","journal-title":"Bioengineered"},{"key":"4874_CR47","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/s41419-024-07156-w","volume":"15","author":"F Exposito","year":"2024","unstructured":"Exposito F, Redrado M, Serrano D, et al. G9a\/DNMT1 co-targeting inhibits non-small cell lung cancer growth and reprograms tumor cells to respond to cancer-drugs through SCARA5 and AOX1. Cell Death Dis. 2024;15:787. https:\/\/doi.org\/10.1038\/s41419-024-07156-w.","journal-title":"Cell Death Dis"},{"key":"4874_CR48","doi-asserted-by":"crossref","unstructured":"Vantaku V, Putluri V, Bader DA, et al. Epigenetic loss of AOX1 expression via EZH2 leads to metabolic deregulations and promotes bladder cancer progression. Oncogene. 2020;39:6265\u201385.","DOI":"10.1038\/s41388-019-0902-7"},{"key":"4874_CR49","doi-asserted-by":"publisher","first-page":"1179212","DOI":"10.3389\/fonc.2023.1179212","volume":"13","author":"X Mo","year":"2023","unstructured":"Mo X, Yuan K, Hu D, et al. Identification and validation of immune-related hub genes based on machine learning in prostate cancer and AOX1 is an oxidative stress-related biomarker. Front Oncol. 2023;13:1179212. https:\/\/doi.org\/10.3389\/fonc.2023.1179212.","journal-title":"Front Oncol"},{"key":"4874_CR50","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1159\/000522634","volume":"107","author":"J Wu","year":"2023","unstructured":"Wu J, Wei Y, Li T, Lin L, Yang Z, Ye L. DNA methylation-mediated lowly expressed AOX1 promotes cell migration and invasion of prostate cancer. Urol Int. 2023;107:517\u201325. https:\/\/doi.org\/10.1159\/000522634.","journal-title":"Urol Int"},{"key":"4874_CR51","doi-asserted-by":"publisher","first-page":"107248","DOI":"10.1016\/j.phrs.2024.107248","volume":"205","author":"L Ren","year":"2024","unstructured":"Ren L, Yi J, Yang Y, et al. Corrigendum to systematic pan-cancer analysis identifies APOC1 as an immunological biomarker which regulates macrophage polarization and promotes tumor metastasis. Pharmacol Res. 2024;205:107248. https:\/\/doi.org\/10.1016\/j.phrs.2024.107248.","journal-title":"Pharmacol Res"},{"key":"4874_CR52","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1186\/s12885-024-12105-z","volume":"24","author":"S Yang","year":"2024","unstructured":"Yang S, Du J, Wang W, Zhou D, Xi X. APOC1 is a prognostic biomarker associated with M2 macrophages in ovarian cancer. BMC Cancer. 2024;24:364. https:\/\/doi.org\/10.1186\/s12885-024-12105-z.","journal-title":"BMC Cancer"},{"key":"4874_CR53","doi-asserted-by":"publisher","first-page":"102463","DOI":"10.1016\/j.redox.2022.102463","volume":"56","author":"X Hao","year":"2022","unstructured":"Hao X, Zheng Z, Liu H, et al. Inhibition of APOC1 promotes the transformation of M2 into M1 macrophages via the ferroptosis pathway and enhances anti-PD1 immunotherapy in hepatocellular carcinoma based on single-cell RNA sequencing. Redox Biol. 2022;56:102463. https:\/\/doi.org\/10.1016\/j.redox.2022.102463.","journal-title":"Redox Biol"},{"key":"4874_CR54","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1007\/s11427-022-2329-7","volume":"66","author":"S Liu","year":"2023","unstructured":"Liu S, Zhang F, Liang Y, et al. Nanoparticle (NP)-mediated APOC1 silencing to inhibit MAPK\/ERK and NF-kappaB pathway and suppress breast cancer growth and metastasis. Sci China Life Sci. 2023;66:2451\u201365. https:\/\/doi.org\/10.1007\/s11427-022-2329-7.","journal-title":"Sci China Life Sci"},{"key":"4874_CR55","doi-asserted-by":"publisher","first-page":"e22158","DOI":"10.1002\/jbt.22158","volume":"32","author":"WP Su","year":"2018","unstructured":"Su WP, Sun LN, Yang SL, et al. Apolipoprotein C1 promotes prostate cancer cell proliferation in vitro. J Biochem Mol Toxicol. 2018;32:e22158. https:\/\/doi.org\/10.1002\/jbt.22158.","journal-title":"J Biochem Mol Toxicol"},{"key":"4874_CR56","doi-asserted-by":"publisher","first-page":"e18511","DOI":"10.1111\/jcmm.18511","volume":"28","author":"H Jiang","year":"2024","unstructured":"Jiang H, Liu M, Deng Y, et al. Identification of prostate cancer bone metastasis related genes and potential therapy targets by bioinformatics and in vitro experiments. J Cell Mol Med. 2024;28:e18511. https:\/\/doi.org\/10.1111\/jcmm.18511.","journal-title":"J Cell Mol Med"},{"key":"4874_CR57","doi-asserted-by":"publisher","first-page":"4207","DOI":"10.7150\/ijbs.64714","volume":"17","author":"H Yang","year":"2021","unstructured":"Yang H, Deng Q, Ni T, et al. Targeted Inhibition of LPL\/FABP4\/CPT1 fatty acid metabolic axis can effectively prevent the progression of nonalcoholic steatohepatitis to liver cancer. Int J Biol Sci. 2021;17:4207\u201322. https:\/\/doi.org\/10.7150\/ijbs.64714.","journal-title":"Int J Biol Sci"},{"key":"4874_CR58","doi-asserted-by":"publisher","first-page":"2085432","DOI":"10.1080\/2162402X.2022.2085432","volume":"11","author":"Z Liu","year":"2022","unstructured":"Liu Z, Gao Z, Li B, et al. Lipid-associated macrophages in the tumor-adipose microenvironment facilitate breast cancer progression. Oncoimmunology. 2022;11:2085432. https:\/\/doi.org\/10.1080\/2162402X.2022.2085432.","journal-title":"Oncoimmunology"},{"key":"4874_CR59","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20210564","author":"M Masetti","year":"2022","unstructured":"Masetti M, Carriero R, Portale F, et al. Lipid-loaded tumor-associated macrophages sustain tumor growth and invasiveness in prostate cancer. J Exp Med. 2022. https:\/\/doi.org\/10.1084\/jem.20210564.","journal-title":"J Exp Med"},{"key":"4874_CR60","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1158\/0008-5472.CAN-21-0914","volume":"82","author":"L Ippolito","year":"2022","unstructured":"Ippolito L, Comito G, Parri M, et al. Lactate rewires lipid metabolism and sustains a metabolic-epigenetic axis in prostate cancer. Cancer Res. 2022;82:1267\u201382. https:\/\/doi.org\/10.1158\/0008-5472.CAN-21-0914.","journal-title":"Cancer Res"},{"key":"4874_CR61","doi-asserted-by":"publisher","first-page":"4791","DOI":"10.7150\/jca.43665","volume":"11","author":"Y He","year":"2020","unstructured":"He Y, Liu XY, Gong R, Peng KW, Liu RB, Wang F. NK homeobox 2.2 functions as tumor suppressor in colorectal cancer due to DNA methylation. J Cancer. 2020;11:4791\u2013800. https:\/\/doi.org\/10.7150\/jca.43665.","journal-title":"J Cancer"},{"key":"4874_CR62","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1016\/j.gendis.2022.10.001","volume":"10","author":"C Mio","year":"2023","unstructured":"Mio C, Baldan F, Damante G. NK2 homeobox gene cluster: functions and roles in human diseases. Genes Dis. 2023;10:2038\u201348. https:\/\/doi.org\/10.1016\/j.gendis.2022.10.001.","journal-title":"Genes Dis"},{"key":"4874_CR63","doi-asserted-by":"publisher","first-page":"104576","DOI":"10.1016\/j.isci.2022.104576","volume":"25","author":"Z Wang","year":"2022","unstructured":"Wang Z, Wang T, Hong D, et al. Single-cell transcriptional regulation and genetic evolution of neuroendocrine prostate cancer. iScience. 2022;25:104576. https:\/\/doi.org\/10.1016\/j.isci.2022.104576","journal-title":"iScience"},{"key":"4874_CR64","doi-asserted-by":"publisher","first-page":"14917","DOI":"10.1038\/ncomms14917","volume":"8","author":"M Xue","year":"2017","unstructured":"Xue M, Liu H, Zhang L, et al. Computational identification of mutually exclusive transcriptional drivers dysregulating metastatic microRNAs in prostate cancer. Nat Commun. 2017;8:14917. https:\/\/doi.org\/10.1038\/ncomms14917.","journal-title":"Nat Commun"},{"key":"4874_CR65","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21145106","author":"HH Chung","year":"2020","unstructured":"Chung HH, Lee CT, Hu JM, Chou YC, Lin YW, Shih YL. NKX6.1 represses tumorigenesis, metastasis, and chemoresistance in colorectal cancer. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21145106.","journal-title":"Int J Mol Sci"},{"key":"4874_CR66","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12929-021-00726-6","volume":"28","author":"PH Su","year":"2021","unstructured":"Su PH, Huang RL, Lai HC, et al. NKX6-1 mediates cancer stem-like properties and regulates sonic hedgehog signaling in leiomyosarcoma. J Biomed Sci. 2021;28:32. https:\/\/doi.org\/10.1186\/s12929-021-00726-6.","journal-title":"J Biomed Sci"},{"key":"4874_CR67","doi-asserted-by":"publisher","first-page":"116802","DOI":"10.1016\/j.bcp.2025.116802","volume":"234","author":"GB-B Xiao-Jia","year":"2025","unstructured":"Xiao-Jia GB-B, Jing Z, Li, et al. Cholesterol metabolism in tumor immunity: Mechanisms and therapeutic opportunities for cancer. Biochem Pharmacol. 2025;234:116802.","journal-title":"Biochem Pharmacol"},{"key":"4874_CR68","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1016\/j.immuni.2023.10.015","volume":"56","author":"S Heegwon","year":"2023","unstructured":"Heegwon S, Chung H. SMPDL3A links cholesterol metabolism to the cGAS-STING pathway. Immunity. 2023;56:2459\u201361.","journal-title":"Immunity"},{"key":"4874_CR69","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.immuni.2025.03.002","volume":"58","author":"Y Liqun","year":"2025","unstructured":"Liqun Y, Keziah L, Yichao S, et al. Tumor-derived arachidonic acid reprograms neutrophils to promote immune suppression and therapy resistance in triple-negative breast cancer. Immunity. 2025;58:909\u201325.","journal-title":"Immunity"},{"key":"4874_CR70","doi-asserted-by":"crossref","unstructured":"Yufang M, Jingsun J, Chong Z, et al. Arachidonic acid metabolism in metabolic dysfunction-associated steatotic liver disease and liver fibrosis. Hepatol Commun. 2025;9:e0802.","DOI":"10.1097\/HC9.0000000000000802"},{"key":"4874_CR71","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3109\/08830185.2014.969421","volume":"34","author":"L Zhu","year":"2015","unstructured":"Zhu L, Zhao Q, Yang T, Ding W, Zhao Y. Cellular metabolism and macrophage functional polarization. Int Rev Immunol. 2015;34:82\u2013100. https:\/\/doi.org\/10.3109\/08830185.2014.969421.","journal-title":"Int Rev Immunol"},{"key":"4874_CR72","doi-asserted-by":"publisher","first-page":"531","DOI":"10.3390\/cells9030531","volume":"9","author":"I Raphael","year":"2020","unstructured":"Raphael I, Joern RR, Forsthuber TG. Memory CD4(+) T cells in immunity and autoimmune diseases. Cells. 2020;9:531. https:\/\/doi.org\/10.3390\/cells9030531","journal-title":"Cells"},{"key":"4874_CR73","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/imr.12426","volume":"272","author":"S Bedoui","year":"2016","unstructured":"Bedoui S, Heath WR, Mueller SN. CD4(+) T-cell help amplifies innate signals for primary CD8(+) T-cell immunity. Immunol Rev. 2016;272:52\u201364. https:\/\/doi.org\/10.1111\/imr.12426.","journal-title":"Immunol Rev"},{"key":"4874_CR74","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/s41590-023-01510-4","volume":"24","author":"M Kunzli","year":"2023","unstructured":"Kunzli M, Masopust D. CD4(+) T cell memory. Nat Immunol. 2023;24:903\u201314. https:\/\/doi.org\/10.1038\/s41590-023-01510-4.","journal-title":"Nat Immunol"},{"key":"4874_CR75","doi-asserted-by":"publisher","first-page":"1615340","DOI":"10.3389\/fimmu.2025.1615340","volume":"16","author":"W Haogeng","year":"2025","unstructured":"Haogeng W, Taixi H, Yuxia. Ma,Mechanisms and therapeutic strategies of macrophages and neutrophils inducing ulcerative colitis progression. Front Immunol. 2025;16:1615340.","journal-title":"Front Immunol"},{"key":"4874_CR76","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1530\/REP-24-0278","volume":"169","author":"SM Chen","year":"2024","unstructured":"Chen SM, Liu YK, Ma XQ. Creatine promotes endometriosis progression by inducing M2 polarization of peritoneal macrophages. Reproduction. 2024;169:3.","journal-title":"Reproduction"},{"key":"4874_CR77","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1007\/s11033-025-10733-7","volume":"52","author":"Y Shuang","year":"2025","unstructured":"Shuang Y, Xiaoming H, Chenxi, Wang, et al. T16 modulated extracellular matrix remodeling in fibroblasts via paracrine activation of TGF-\u03b21 through M2 macrophage polarization. Mol Biol Rep. 2025;52:642.","journal-title":"Mol Biol Rep"},{"key":"4874_CR78","doi-asserted-by":"publisher","first-page":"103564","DOI":"10.1016\/j.redox.2025.103564","volume":"83","author":"W Jiewen","year":"2025","unstructured":"Jiewen W. Insights and perspectives on the role of APOC1 inhibition in modulating immunotherapy outcomes in HCC: Commentary on Inhibition of APOC1 promotes the transformation of M2 into M1 macrophages via the ferroptosis pathway and enhances anti-PD1 immunotherapy in hepatocellular carcinoma based on single-cell RNA sequencing. Redox Biol. 2025;83:103564..","journal-title":"Redox Biol"},{"key":"4874_CR79","doi-asserted-by":"publisher","first-page":"34724","DOI":"10.1038\/s41598-025-18392-1","volume":"15","author":"G Fengran","year":"2025","unstructured":"Fengran G, Ziyang M, Hu, Wang, et al. Transcriptome analysis combined with single-cell analysis identified that APOC1 influences cholesterol transport by macrophages in ccRCC. Sci Rep. 2025;15:34724.","journal-title":"Sci Rep"},{"key":"4874_CR80","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12967-023-04807-y","volume":"22","author":"W Wang","year":"2024","unstructured":"Wang W, Li T, Xie Z, et al. Integrating single-cell and bulk RNA sequencing data unveils antigen presentation and process-related CAFS and establishes a predictive signature in prostate cancer. J Transl Med. 2024;22:57. https:\/\/doi.org\/10.1186\/s12967-023-04807-y.","journal-title":"J Transl Med"},{"key":"4874_CR81","doi-asserted-by":"publisher","first-page":"965571","DOI":"10.3389\/fonc.2022.965571","volume":"12","author":"G Sun","year":"2022","unstructured":"Sun G, Ma S, Zheng Z, et al. Multi-omics analysis of expression and prognostic value of NSUN members in prostate cancer. Front Oncol. 2022;12:965571. https:\/\/doi.org\/10.3389\/fonc.2022.965571.","journal-title":"Front Oncol"},{"key":"4874_CR82","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1007\/s12094-022-02857-0","volume":"24","author":"J Liao","year":"2022","unstructured":"Liao J, Ye Y, Xu X. Comprehensive analysis of tumor mutation burden and immune microenvironment in prostate cancer. Clin Transl Oncol. 2022;24:1986\u201397. https:\/\/doi.org\/10.1007\/s12094-022-02857-0.","journal-title":"Clin Transl Oncol"},{"key":"4874_CR83","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9061973","author":"NK Jairath","year":"2020","unstructured":"Jairath NK, Farha MW, Srinivasan S, et al. Tumor immune microenvironment clusters in localized prostate adenocarcinoma: prognostic impact of macrophage enriched\/plasma cell non-enriched subtypes. J Clin Med. 2020. https:\/\/doi.org\/10.3390\/jcm9061973.","journal-title":"J Clin Med"},{"key":"4874_CR84","doi-asserted-by":"publisher","first-page":"e2303894","DOI":"10.1002\/advs202303894","volume":"11","author":"H Xiao","year":"2024","unstructured":"Xiao H, Du X, Tao Z, et al. Taurine inhibits ferroptosis mediated by the crosstalk between tumor cells and tumor-associated macrophages in prostate cancer. Adv Sci (Weinh). 2024;11:e2303894. https:\/\/doi.org\/10.1002\/advs.202303894.","journal-title":"Adv Sci (Weinh)"},{"key":"4874_CR85","doi-asserted-by":"publisher","unstructured":"Ou Y, Xia C, Ye C, et al. Comprehensive scRNA-seq analysis to identify new markers of M2 macrophages for predicting the prognosis of prostate cancer. Ann Med. 2024;56:2398195. https:\/\/doi.org\/10.1080\/07853890.2024.2398195.","DOI":"10.1080\/07853890.2024.2398195"},{"key":"4874_CR86","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-006020","author":"S Chen","year":"2023","unstructured":"Chen S, Lu K, Hou Y, et al. YY1 complex in M2 macrophage promotes prostate cancer progression by upregulating IL-6. J Immunother Cancer. 2023. https:\/\/doi.org\/10.1136\/jitc-2022-006020.","journal-title":"J Immunother Cancer"},{"key":"4874_CR87","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1007\/s12672-025-02484-5","volume":"16","author":"W Zhenwei","year":"2025","unstructured":"Zhenwei W, Zhihong D, Yuren G, et al. Development of a machine learning-based predictive risk model combining fatty acid metabolism and ferroptosis for immunotherapy response and prognosis in prostate cancer. Discov Oncol. 2025;16:744. https:\/\/pubmed.ncbi.nlm.nih.gov\/40355680\/.","journal-title":"Discov Oncol"},{"key":"4874_CR88","first-page":"283","volume":"132","author":"C Ming","year":"2024","unstructured":"Ming C, Siqi Z, Xiongwei H, et al. Identification of diagnostic biomarkers in prostate cancer-related fatigue by construction of predictive models and experimental validation. Br J Cancer. 2024;132:283\u201394.","journal-title":"Br J Cancer"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-04874-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04874-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04874-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:14:26Z","timestamp":1777508066000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-04874-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,22]]},"references-count":88,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4874"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-04874-9","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,22]]},"assertion":[{"value":"12 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"661"}}